Pacira Pharmaceuticals Inc (PCRX)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	41,955	15,909	41,980	145,523	-11,016
Revenue	US$ in thousands	636,266	626,907	541,533	429,647	421,026
Net profit margin		6.59%	2.54%	7.75%	33.87%	-2.62%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $41,955K ÷ $636,266K
= 6.59%

Pacira BioSciences Inc's net profit margin has displayed fluctuating trends over the past five years. In 2023, the net profit margin was 6.22%, showing an improvement compared to the prior year's margin of 2.39%. However, it fell short of the margin reported in 2021, when it was 7.75%. The significant drop in net profit margin from 2020 to 2019, going from 33.87% to -2.62%, indicates a notable shift in the company's profitability dynamics. Overall, while the recent improvement in net profit margin is a positive sign, further analysis is necessary to understand the underlying factors driving these fluctuations.